No Chemo? How Immunotherapy Is Shifting the Lung Cancer Landscape

24 Visioni
Published
A New Era in Lung Cancer Treatment: Immunotherapy Offers Real Hope
For decades, a lung cancer diagnosis meant limited options and an uncertain future. But today, thanks to groundbreaking immunotherapy and targeted therapies, patients are not only living longer, they are living better.
In this powerful video, Lung Cancer Foundation of America (LCFA) funded researcher Dr. Kellie Smith, an Associate Professor of Oncology at the Bloomberg Kimmel Institute for Cancer Immunotherapy at Johns Hopkins Medicine, shares how immunotherapy transforms lung cancer treatment. Instead of relying solely on chemotherapy, many patients now receive treatments that help their immune systems fight the disease, often with fewer side effects and longer-lasting results.
What started as a “hmm” moment in research labs now saves lives nationwide.
LCFA Patient Advocate Jane Perlmutter explains how these breakthroughs have allowed her and many others to live years beyond diagnosis with a good quality of life.
These advancements did not happen overnight. They result from decades of research, clinical trials, and ongoing support from organizations like the Lung Cancer Foundation of America (LCFA).
If you or someone you love is facing lung cancer, now is the time to ask about immunotherapy and clinical trials. The future is brighter, and it starts with research.
Learn more and support the science at LCFAmerica.org
#LCFA #LungCancerResearch
Categoria
Oncology
Commenta per primo questo video.